Prognostic factors of melanoma patients with satellite or in-transit metastasis at the time of stage III diagnosis.

by Benjamin Weide, Christine Faller, Petra Büttner, Annette Pflugfelder, Ulrike Leiter, Thomas Kurt Eigentler, Jürgen Bauer, Andrea Forschner, Friedegund Meier, Claus Garbe
Published 2013-01-01

Melanoma patients with unknown primary site or nodal recurrence after initial diagnosis have a favourable survival compared to those with synchronous lymph node metastasis and prim...

by Benjamin Weide, Christine Faller, Margrit Elsässer, Petra Büttner, Annette Pflugfelder, Ulrike Leiter, Thomas Kurt Eigentler, Jürgen Bauer, Friedegund Meier, Claus Garbe
Published 2013-01-01

Wnt-signaling enhances neural crest migration of melanoma cells and induces an invasive phenotype

by Tobias Sinnberg, Mitchell P. Levesque, Jelena Krochmann, Phil F. Cheng, Kristian Ikenberg, Francisco Meraz-Torres, Heike Niessner, Claus Garbe, Christian Busch
Published 2018-02-01

BRAF-V600 mutations have no prognostic impact in stage IV melanoma patients treated with monochemotherapy.

by Diana Meckbach, Ulrike Keim, Sabina Richter, Ulrike Leiter, Thomas K Eigentler, Jürgen Bauer, Annette Pflugfelder, Petra Büttner, Claus Garbe, Benjamin Weide
Published 2014-01-01

Serum S100B, lactate dehydrogenase and brain metastasis are prognostic factors in patients with distant melanoma metastasis and systemic therapy.

by Benjamin Weide, Sabina Richter, Petra Büttner, Ulrike Leiter, Andrea Forschner, Jürgen Bauer, Laura Held, Thomas Kurt Eigentler, Friedegund Meier, Claus Garbe
Published 2013-01-01

A Systematic Review and Meta-Analysis of Interventions for Actinic Keratosis from Post-Marketing Surveillance Trials

by Theresa Steeb, Anja Wessely, Matthias Harlaß, Franz Heppt, Elias A. T. Koch, Ulrike Leiter, Claus Garbe, Oliver Schöffski, Carola Berking, Markus V. Heppt
Published 2020-07-01

Primary Resistance to PD-1-Based Immunotherapy—A Study in 319 Patients with Stage IV Melanoma

by Teresa Amaral, Olivia Seeber, Edgar Mersi, Stephanie Sanchez, Ioannis Thomas, Andreas Meiwes, Andrea Forschner, Ulrike Leiter, Thomas Eigentler, Ulrike Keim, Claus Garbe
Published 2020-04-01

Modifiable Risk-factors for Keratinocyte Cancers in Australia: A Case-control Study

by Lina Maria Serna-Higuita, Simone L. Harrison, Petra Buttner, Margaret Glasby, Beverly A. Raasch, Angelika Iftner, Claus Garbe, Peter Martus, Thomas Iftner
Published 2019-02-01

Primary localization and tumor thickness as prognostic factors of survival in patients with mucosal melanoma.

by Tarun Mehra, Gerd Grözinger, Steven Mann, Emmanuella Guenova, Rudolf Moos, Martin Röcken, Claus Detlef Claussen, Reinhard Dummer, Stephan Clasen, Aline Naumann, Claus Garbe
Published 2014-01-01

Tumour Progression Stage-Dependent Secretion of YB-1 Stimulates Melanoma Cell Migration and Invasion

by Corinna Kosnopfel, Tobias Sinnberg, Birgit Sauer, Heike Niessner, Alina Muenchow, Birgit Fehrenbacher, Martin Schaller, Peter R. Mertens, Claus Garbe, Basant Kumar Thakur, Birgit Schittek
Published 2020-08-01

Distinct Mutation Patterns Reveal Melanoma Subtypes and Influence Immunotherapy Response in Advanced Melanoma Patients

by Franz J. Hilke, Tobias Sinnberg, Axel Gschwind, Heike Niessner, German Demidov, Teresa Amaral, Stephan Ossowski, Irina Bonzheim, Martin Röcken, Olaf Riess, Claus Garbe, Christopher Schroeder, Andrea Forschner
Published 2020-08-01

A Nexus Consisting of Beta-Catenin and Stat3 Attenuates BRAF Inhibitor Efficacy and Mediates Acquired Resistance to Vemurafenib

by Tobias Sinnberg, Elena Makino, Marcel A. Krueger, Ana Velic, Boris Macek, Ulrich Rothbauer, Nicola Groll, Oliver Pötz, Stefan Czemmel, Heike Niessner, Friedegund Meier, Kristian Ikenberg, Claus Garbe, Birgit Schittek
Published 2016-06-01

6- and 8-Prenylnaringenin, Novel Natural Histone Deacetylase Inhibitors Found in Hops, Exert Antitumor Activity on Melanoma Cells

by Sascha Venturelli, Heike Niessner, Tobias Sinnberg, Alexander Berger, Markus Burkard, Corinna Urmann, Kathrin Donaubauer, Alexander Böcker, Christian Leischner, Herbert Riepl, Jan Frank, Ulrich M Lauer, Claus Garbe, Christian Busch
Published 2018-11-01

Peripheral PD-1+CD56+ T-cell frequencies correlate with outcome in stage IV melanoma under PD-1 blockade.

by Jonas Bochem, Henning Zelba, Teresa Amaral, Janine Spreuer, Daniel Soffel, Thomas Eigentler, Nikolaus Benjamin Wagner, Ugur Uslu, Patrick Terheyden, Friedegund Meier, Claus Garbe, Graham Pawelec, Benjamin Weide, Kilian Wistuba-Hamprecht
Published 2019-01-01

433 Talimogene laherparepvec (T-VEC) in combination with ipilimumab (IPI) versus IPI alone for advanced melanoma: 4-year interim analysis of a randomized, open-label, phase 2 trial...

by Min Yi, Celeste Lebbe, Parminder Singh, Omid Hamid, Jason Chesney, Igor Puzanov, Mohammed Milhem, Merrick Ross, Janice Mehnert, Theodore Logan, Philip Friedlander, Frances Collichio, Claus Garbe, John Glaspy, Axel Hauschild, Wendy Snyder
Published 2020-11-01

MDM2, MDM4 and EGFR Amplifications and Hyperprogression in Metastatic Acral and Mucosal Melanoma

by Andrea Forschner, Franz-Joachim Hilke, Irina Bonzheim, Axel Gschwind, German Demidov, Teresa Amaral, Stephan Ossowski, Olaf Riess, Christopher Schroeder, Peter Martus, Bernhard Klumpp, Irene Gonzalez-Menendez, Claus Garbe, Heike Niessner, Tobias Sinnberg
Published 2020-02-01

Survival according to BRAF-V600 tumor mutations--an analysis of 437 patients with primary melanoma.

by Diana Meckbach, Jürgen Bauer, Annette Pflugfelder, Friedegund Meier, Christian Busch, Thomas K Eigentler, David Capper, Andreas von Deimling, Michel Mittelbronn, Sven Perner, Kristian Ikenberg, Markus Hantschke, Petra Büttner, Claus Garbe, Benjamin Weide
Published 2014-01-01

Quantitative measurement of melanoma spread in sentinel lymph nodes and survival.

by Anja Ulmer, Klaus Dietz, Isabelle Hodak, Bernhard Polzer, Sebastian Scheitler, Murat Yildiz, Zbigniew Czyz, Petra Lehnert, Tanja Fehm, Christian Hafner, Stefan Schanz, Martin Röcken, Claus Garbe, Helmut Breuninger, Gerhard Fierlbeck, Christoph A Klein
Published 2014-02-01

Phase II DeCOG-study of ipilimumab in pretreated and treatment-naïve patients with metastatic uveal melanoma.

by Lisa Zimmer, Julia Vaubel, Peter Mohr, Axel Hauschild, Jochen Utikal, Jan Simon, Claus Garbe, Rudolf Herbst, Alexander Enk, Eckhart Kämpgen, Elisabeth Livingstone, Leonie Bluhm, Rainer Rompel, Klaus G Griewank, Michael Fluck, Bastian Schilling, Dirk Schadendorf
Published 2015-01-01

Tumor mutation burden and circulating tumor DNA in combined CTLA-4 and PD-1 antibody therapy in metastatic melanoma – results of a prospective biomarker study

by Andrea Forschner, Florian Battke, Dirk Hadaschik, Martin Schulze, Stephanie Weißgraeber, Chung-Ting Han, Maria Kopp, Maximilian Frick, Bernhard Klumpp, Nicola Tietze, Teresa Amaral, Peter Martus, Tobias Sinnberg, Thomas Eigentler, Ulrike Keim, Claus Garbe, Dennis Döcker, Saskia Biskup
Published 2019-07-01